Fatima Aouidat1, Sarah Boumati2, Memona Khan1, Frederik Tielens3, Bich-Thuy Doan2, Jolanda Spadavecchia1. 1. CNRS, UMR 7244, CSPBAT, Laboratory of Chemistry, Structures and Properties of Biomaterials And Therapeutic Agents University Paris 13, Sorbonne Paris Cité, Bobigny, France. 2. UTCBS - Chimie ParisTech - University Paris Descartes - CNRS UMR 8258 - INSERM U1022 Equipe "Synthesis, Electrochemistry, Imaging and Analytical Systems for Diagnostics" SEISAD, Paris, France. 3. General Chemistry (ALGC), Vrije University of Brussel (Free University Brussels-VUB), Brussel, Belgium.
Abstract
INTRODUCTION: The development of biopolymers for the synthesis of Gd(III) nanoparticles, as therapeutics, could play a key role in nanomedicine. Biocompatible polymers are not only used for complex monovalent biomolecules, but also for the realization of multivalent active targeting materials as diagnostic and/or therapeutic hybrid nanoparticles. In this article, it was reported for the first time, a novel synthesis of Gd(III)-biopolymer-Au(III) complex, acting as a key ingredient of core-shell gold nanoparticles (Gd(@AuNPs). MATERIAL AND METHODS: The physical and chemical evaluation was carried out by spectroscopic analytical techniques (Raman spectroscopy, UV-visible and TEM). The theoretical characterization by DFT (density functional theory) analysis was carried out under specific conditions to investigate the interaction between the Au and the Gd precursors, during the first nucleation step. Magnetic features with relaxivity measurements at 7T were also performed as well as cytotoxicity studies on hepatocyte cell lines for biocompatibility studies. The in vivo detailed dynamic biodistribution studies in mice to characterize the potential applications for biology as MRI contrast agents were then achieved. RESULTS: Physical-chemical evaluation confirms the successful design and reaction supposed. Viabilities of TIB-75 (hepatocytes) cells were evaluated using Alamar blue cytotoxic tests with increasing concentrations of nanoparticles. In vivo biodistribution studies were then accomplished to assess the kinetic behavior of the nanoparticles in mice and characterize their stealthiness property after intravenous injection. CONCLUSION: We demonstrated that Gd@AuNPs have some advantages to display hepatocytes in the liver. Particularly, these nanoconjugates give a good cellular uptake of several quantities of Gd@NPs into cells, while preserving a T1 contrast inside cells that provide a robust in vivo detection using T1-weighted MR images. These results will strengthen the role of gadolinium as complex to gold in order to tune Gd(@AuNPs) as an innovative diagnostic agent in the field of nanomedicine.
INTRODUCTION: The development of biopolymers for the synthesis of Gd(III) nanoparticles, as therapeutics, could play a key role in nanomedicine. Biocompatible polymers are not only used for complex monovalent biomolecules, but also for the realization of multivalent active targeting materials as diagnostic and/or therapeutic hybrid nanoparticles. In this article, it was reported for the first time, a novel synthesis of Gd(III)-biopolymer-Au(III) complex, acting as a key ingredient of core-shell gold nanoparticles (Gd(@AuNPs). MATERIAL AND METHODS: The physical and chemical evaluation was carried out by spectroscopic analytical techniques (Raman spectroscopy, UV-visible and TEM). The theoretical characterization by DFT (density functional theory) analysis was carried out under specific conditions to investigate the interaction between the Au and the Gd precursors, during the first nucleation step. Magnetic features with relaxivity measurements at 7T were also performed as well as cytotoxicity studies on hepatocyte cell lines for biocompatibility studies. The in vivo detailed dynamic biodistribution studies in mice to characterize the potential applications for biology as MRI contrast agents were then achieved. RESULTS: Physical-chemical evaluation confirms the successful design and reaction supposed. Viabilities of TIB-75 (hepatocytes) cells were evaluated using Alamar blue cytotoxic tests with increasing concentrations of nanoparticles. In vivo biodistribution studies were then accomplished to assess the kinetic behavior of the nanoparticles in mice and characterize their stealthiness property after intravenous injection. CONCLUSION: We demonstrated that Gd@AuNPs have some advantages to display hepatocytes in the liver. Particularly, these nanoconjugates give a good cellular uptake of several quantities of Gd@NPs into cells, while preserving a T1 contrast inside cells that provide a robust in vivo detection using T1-weighted MR images. These results will strengthen the role of gadolinium as complex to gold in order to tune Gd(@AuNPs) as an innovative diagnostic agent in the field of nanomedicine.
Authors: Nicola D'Amelio; Carmen Esteban; Anna Coslovi; Luigi Feruglio; Fulvio Uggeri; Myriam Villegas; Julio Benegas; Sergio Paoletti; Ivan Donati Journal: J Phys Chem B Date: 2013-10-18 Impact factor: 2.991
Authors: Ying Song; Xiaoyang Xu; Keith W MacRenaris; Xue-Qing Zhang; Chad A Mirkin; Thomas J Meade Journal: Angew Chem Int Ed Engl Date: 2009 Impact factor: 15.336
Authors: Hoang D Lu; Leon Z Wang; Brian K Wilson; Simon A McManus; Jenny Jumai'an; Prashanth K Padakanti; Abass Alavi; Robert H Mach; Robert K Prud'homme Journal: ACS Appl Mater Interfaces Date: 2018-01-17 Impact factor: 9.229
Authors: Dmitry V Korolev; Galina A Shulmeyster; Maria S Istomina; Natalia V Evreinova; Ilia V Aleksandrov; Aleksandr S Krasichkov; Viktor N Postnov; Michael M Galagudza Journal: Materials (Basel) Date: 2022-05-27 Impact factor: 3.748